|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6700 CAD | -1.47% |
|
-9.46% | -20.24% |
Company Valuation: Healwell AI Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 61.13 | 30.05 | 65.99 | 356 | 197.1 | 197.1 | - |
| Change | - | -50.85% | 119.64% | 439.5% | -44.65% | 0% | - |
| Enterprise Value (EV) 1 | 55.71 | 35.67 | 65.99 | 356 | 255.4 | 254.4 | 242.8 |
| Change | - | -35.97% | 85.01% | 439.5% | -28.27% | -0.37% | -4.58% |
| P/E ratio | -3.79x | -1.43x | -1.36x | -11.1x | -3.42x | -5.98x | -8.38x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0.1x | -0x | 0.2x | -1.08x | 0.1x | 0.3x |
| Capitalization / Revenue | 1.28x | 0.56x | 9.02x | 9.14x | 1.92x | 1.44x | 1.25x |
| EV / Revenue | 1.17x | 0.67x | 9.02x | 9.14x | 2.48x | 1.86x | 1.53x |
| EV / EBITDA | -12x | -3.81x | -8.3x | -22.2x | 134x | 28.4x | 16.3x |
| EV / EBIT | -3.7x | - | -3.92x | -10.6x | -7.34x | -8.11x | -8.99x |
| EV / FCF | -7.02x | -4.12x | - | -13.5x | -10.3x | -46.3x | 143x |
| FCF Yield | -14.2% | -24.3% | - | -7.4% | -9.67% | -2.16% | 0.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -0.33 | -0.42 | -0.55 | -0.19 | -0.196 | -0.112 | -0.08 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 47.82 | 53.22 | 7.317 | 38.97 | 102.8 | 136.6 | 158.3 |
| EBITDA 1 | -4.644 | -9.356 | -7.954 | -16 | 1.901 | 8.961 | 14.85 |
| EBIT 1 | -15.06 | - | -16.82 | -33.58 | -34.8 | -31.36 | -26.99 |
| Net income 1 | -15.67 | - | -31.54 | -25.46 | -51.86 | -35.27 | -22.64 |
| Net Debt 1 | -5.422 | 5.623 | - | - | 58.3 | 57.35 | 45.7 |
| Reference price 2 | 1.2500 | 0.6000 | 0.7500 | 2.1100 | 0.6700 | 0.6700 | 0.6700 |
| Nbr of stocks (in thousands) | 48,905 | 50,075 | 87,987 | 168,729 | 294,123 | 294,123 | - |
| Announcement Date | 3/31/22 | 3/31/23 | 3/28/24 | 3/26/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.42x | 2.48x | 134.32x | - | 145M | ||
| 32.87x | 6.93x | 15.3x | -.--% | 28.62B | ||
| 57.32x | 44.18x | 51.23x | 0.68% | 8.73B | ||
| 64.32x | 9.69x | 43.22x | 1.15% | 3.92B | ||
| -7.8x | 13.96x | -51.61x | - | 1.76B | ||
| 123.73x | - | - | -.--% | 1.64B | ||
| -109.32x | - | - | - | 1.37B | ||
| 548x | - | - | 0.55% | 1.23B | ||
| Average | 88.21x | 15.45x | 38.49x | 0.48% | 5.92B | |
| Weighted average by Cap. | 50.70x | 14.98x | 22.77x | 0.25% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- AIDX Stock
- Valuation Healwell AI Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















